Evidence map›Paper›PMID 27317688›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2016

A new experimental model of acid- and endotoxin-induced acute lung injury in rats.

F Puig, R Herrero, R Guillamat-Prats, M N Gómez, J Tijero, L Chimenti, O Stelmakh, L Blanch, A Serrano-Mollar, M A Matthay and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Translational medicine for acute lung injury.Journal of translational medicine · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

F PuigCIBER de Enfermedades Respiratorias, Madrid, Spain; Critical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain; ferranda@gmail.com.ORCID 0000-0002-3634-0950
R HerreroCIBER de Enfermedades Respiratorias, Madrid, Spain; Intensive Care Medicine Service, Hospital Universitario de Getafe, Getafe, Spain;
R Guillamat-PratsCIBER de Enfermedades Respiratorias, Madrid, Spain; Critical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
M N GómezCritical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
J TijeroCritical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
L ChimentiCritical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
O StelmakhLaboratorio de Análisis Clínico, Hospital Universitario de Getafe, Getafe, Spain;
L BlanchCIBER de Enfermedades Respiratorias, Madrid, Spain; Critical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
A Serrano-MollarCIBER de Enfermedades Respiratorias, Madrid, Spain; Instituto de Investigaciones Biomédicas de Barcelona, CSIC, Barcelona, Spain; and.
M A MatthayDepartments of Medicine and Anesthesia and the Cardiovascular Research Institute, University of California, San Francisco, California.
A ArtigasCIBER de Enfermedades Respiratorias, Madrid, Spain; Critical Care Center, Corporació Sanitària i Universitària Parc Taulí, Institut d' Investigació i Innovació Parc Taulí, Sabadell, Spain;
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESInstitute of Research and Innovation Parc Tauli · ESHospital Universitario de Getafe · ESUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of the animal models of acute lung injury (ALI) are focused on the acute phase. This limits the studies of the mechanisms involved in later phases and the effects of long-term treatments. Thus the goal of this study was to develop an experimental ALI model of aspiration pneumonia, in which diffuse alveolar damage continues for 72 h. Rats were intratracheally instilled with one dose of HCl (0.1 mol/l) followed by another instillation of one dose of LPS (0, 10, 20, 30, or 40 μg/g body weight) 2 h later, which models aspiration of gastric contents that progresses to secondary lung injury from bacteria or bacterial products. The rats were euthanized at 24, 48, and 72 h after the last instillation. The results showed that HCl and LPS at all doses caused activation of inflammatory responses, increased protein permeability and apoptosis, and induced mild hypoxemia in rat lungs at 24 h postinstillation. However, this lung damage was present at 72 h only in rats receiving HCl and LPS at the doses of 30 and 40 μg/g body wt. Mortality (∼50%) occurred in the first 48 h and only in the rats treated with HCl and LPS at the highest dose (40 μg/g body wt). In conclusion, intratracheal instillation of HCl followed by LPS at the dose of 30 μg/g body wt results in severe diffuse alveolar damage that continues at least 72 h. This rat model of aspiration pneumonia-induced ALI will be useful for testing long-term effects of new therapeutic strategies in ALI.

Indexed as

Acute Lung InjuryAnimalsApoptosisDisease Models, AnimalHydrochloric AcidLipopolysaccharidesMalePulmonary AlveoliRats, Sprague-DawleyHydrochloric AcidLipopolysaccharidesacute lung injurygastric aspiration pneumoniaLPSrat modelVEGF

Identifiers

PMID27317688
PMCPMC5142457
OpenAlexW2425526600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.